When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues…
Colon cancer is the third leading cause of cancer-related deaths in the U.S., but early detection saves lives. This video explains how colon cancer starts as slow-growing polyps…
In this insightful discussion on the Rena Malik MD podcast, Rena Malik, MD interviews Stacy Loeb, MD, a Professor of Urology at New York University. They explore the…
Christopher Patriquin, MD, Hematologist at Toronto General Hospital, discusses the challenges of diagnosing paroxysmal nocturnal hemoglobinuria (PNH) due to its varied symptoms, such as thrombosis, anemia, and unusual…
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disease where red blood cells rupture due to the immune system mistakenly attacking them. This happens because of a mutation…
Antonio Risitano, MD, PhD, highlights exciting developments in treatments for paroxysmal nocturnal hemoglobinuria (PNH), specifically the introduction of complement inhibitors that have transformed the prognosis of the disease.…
The meeting discusses the effectiveness and value of treatments for paroxysmal nocturnal hemoglobinuria (PNH). During the session, individual members introduce themselves, disclose conflicts of interest, and emphasize patient…
Physicians at Sanjay Gandhi Postgraduate Institute of Medical Sciences successfully managed a pregnancy in a patient with Paroxysmal Nocturnal Hemoglobinuria (PNH), a rare blood disorder. Despite the high…
This session focused on patient-reported outcomes for Paroxysmal Nocturnal Hemoglobinuria (PNH) and how the disease and current treatments affect patient lives. A key highlight was a Ukrainian patient’s…
Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare hemolytic anemia caused by a mutation in the PIGA gene, which disrupts the production of protective proteins (CD55 and CD59) on…
James Edwards explains Paroxysmal Nocturnal Hemoglobinuria (PNH), a rare blood disorder caused by a mutation in the PIGA gene, which affects the GPI anchor proteins that protect red…
